Login to Your Account



DRUG PRICE CONTROL TOPS THE LIST

Chinese authorities list New Year’s resolutions

By Shannon Ellis
Staff Writer

Wednesday, March 5, 2014

HONG KONG – After a rocky year for many biopharma companies in China hit hard by bribery investigations companies may find some hopeful points in the overall trend of stricter supervision and punishment in the government’s list of priorities for health care enforcement.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription